These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 22397558

  • 1. Targets for immunochemotherapy in leishmaniasis.
    Mukhopadhyay D, Saha P, Chatterjee M.
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):261-4. PubMed ID: 22397558
    [No Abstract] [Full Text] [Related]

  • 2. Leishmaniasis and various immunotherapeutic approaches.
    Taslimi Y, Zahedifard F, Rafati S.
    Parasitology; 2018 Apr; 145(4):497-507. PubMed ID: 27974063
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunotherapy in treatment of leishmaniasis.
    Akbari M, Oryan A, Hatam G.
    Immunol Lett; 2021 May; 233():80-86. PubMed ID: 33771555
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of cutaneous leishmaniasis].
    Lambert D, Mambre B.
    Ann Dermatol Venereol; 1988 May; 115(5):641-3. PubMed ID: 3058010
    [No Abstract] [Full Text] [Related]

  • 6. Current status and perspectives of the immunotherapy of leishmaniasis.
    El-On J.
    Isr Med Assoc J; 2009 Oct; 11(10):623-8. PubMed ID: 20077951
    [Abstract] [Full Text] [Related]

  • 7. Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis.
    Pereira BA, Alves CR.
    Vet Parasitol; 2008 Dec 20; 158(4):239-55. PubMed ID: 18922635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis.
    Sundar S, Murray HW.
    J Assoc Physicians India; 1995 May 20; 43(5):348-50. PubMed ID: 9081967
    [No Abstract] [Full Text] [Related]

  • 10. Immunomodulation of murine leishmaniasis with cyclosporin A.
    Behforouz NC, Wenger CD.
    Adv Exp Med Biol; 1988 May 20; 239():379-84. PubMed ID: 3202041
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Three decades of clinical trials on immunotherapy for human leishmaniases: a systematic review and meta-analysis.
    Mota CA, Oyama J, Souza Terron Monich M, Brustolin AÁ, Perez de Souza JV, Murase LS, Ghiraldi Lopes LD, Silva Santos TD, Vieira Teixeira JJ, Verzignassi Silveira TG.
    Immunotherapy; 2021 Jun 20; 13(8):693-721. PubMed ID: 33853344
    [Abstract] [Full Text] [Related]

  • 13. Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran.
    Jafari S, Hajiabdolbaghi M, Mohebali M, Hajjaran H, Hashemian H.
    East Mediterr Health J; 2010 Mar 20; 16(3):340-3. PubMed ID: 20795452
    [No Abstract] [Full Text] [Related]

  • 14. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
    Kram D, Thäle C, Kolodziej H, Kiderlen AF.
    J Immunol Methods; 2008 Apr 20; 333(1-2):79-88. PubMed ID: 18313691
    [Abstract] [Full Text] [Related]

  • 15. Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
    Fernandes AP, Carvalho FA, Tavares CA, Santiago HC, Castro GA, Tafuri WL, Ferreira LA, Gazzinelli RT.
    J Infect Dis; 2001 Jun 01; 183(11):1646-52. PubMed ID: 11343214
    [Abstract] [Full Text] [Related]

  • 16. Atypical localization of Leishmaniasis in an intestinal polyp.
    Zaffiri L, d'Ettorre G, Massetti AP, Mascellino MT, Mastroianni CM, Vullo V.
    Infection; 2008 Mar 01; 36(2):187-8. PubMed ID: 18327682
    [No Abstract] [Full Text] [Related]

  • 17. Leishmaniasis.
    Manson-Bahr PE.
    Int Rev Trop Med; 1971 Mar 01; 4():123-40. PubMed ID: 4944092
    [No Abstract] [Full Text] [Related]

  • 18. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
    Pershin GN, Moskalenko NIu.
    Med Parazitol (Mosk); 1967 Mar 01; 36(4):422-7. PubMed ID: 5612807
    [No Abstract] [Full Text] [Related]

  • 19. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE, Schwendener RA, Osso JA, de Andrade HF, do Nascimento N.
    Int J Antimicrob Agents; 2011 Oct 01; 38(4):341-7. PubMed ID: 21783345
    [Abstract] [Full Text] [Related]

  • 20. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H, Hockertz S.
    Arzneimittelforschung; 1999 Nov 01; 49(11):954-61. PubMed ID: 10604050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.